c-myc Overexpression is not mandatory aggressive-phase multiple myeloma with Burkitt's type translocation

Annals of Hematology

Volumn 79, Issue 9, 2000, Pages 514-518

  Kuroda, J ^a   Kimura, S ^a   Akaogi, T ^a   Hayashi, H ^a   Nishida, K ^b   Taniwaki, M ^b   Kashima, K ^b   Abe, T ^b   Kobayashi, Y ^b   Kondo, M ^b  

^a KYOTO SECOND RED CROSS HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Aggressive phase multiple myeloma; Burkitt's type translocation; c myc; Double color fluorescence in situ hybridization

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DEXAMETHASONE; MELPHALAN; PREDNISOLONE; RANIMUSTINE; VINCRISTINE SULFATE;

AGED; ARTICLE; BURKITT LYMPHOMA; CASE REPORT; CHROMOSOME 8Q; CHROMOSOME TRANSLOCATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; HUMAN; HUMAN CELL; MALE; MULTIPLE MYELOMA; MYELOMA CELL; ONCOGENE C MYC; PRIORITY JOURNAL;

AGED; CASE REPORT; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 8; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMAN; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MULTIPLE MYELOMA; PROTO-ONCOGENE PROTEINS C-MYC; TRANSLOCATION (GENETICS);

EID: 0033801920     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770000160     Document Type: Article

References (25)

1. Aggressive phase multiple myeloma: A terminal anaplastic transformation resembling high-grade lymphoma
2. IgH translocation in multiple myeloma: A nearly universal event that rarely involves c-myc
3. Cellular and molecular genetic feature of myeloma and related disorders
4. Human c-myc oncogene is located on the region of chromosome 8 that is translocated in Burkitt's lymphoma cells
5. Cellular and molecular genetic feature of myeloma and related disorders
6. A clinical staging system for multiple myeloma: Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
7. Oncogene activation by chromosome translocation in human malignancy
8. Localization of craniosynostosis Adelaide type to 4p16
9. Hematopoietic stem cell deficiencies in mice lacking c-Mpl, the receptor for thrombopoietin
10. Alterations of c-myc expression by antisense oligodeoxynucleotides enhance the induction of apoptosis in HL-60 cells
11. Myc rearrangement and translocation involving band 8q24 in diffuse large cell lymphomas
12. A novel cyclin encoded by a bcl1-linked candidate oncogene
13. Analysis of BCL2 and MYC expression in non-Hodgkin's lymphomas by in situ hybridization: Correlation with chromosome translocations
14. Nonrandam rearrangement of chromosome 14 at band q32.33 in human lymphoid malignancies with mature B-cell pheno-type
15. Increased expression of the c-myc gene may be related to the aggressive transformation of human myeloma cells
16. Analysis of methylation in the c-MYC gene in five human myeloma cell lines
17. Aberrant translational control of the c-myc gene in multiple myeloma
18. Expression of c-myc proto-oncogene in normal human lymphocytes. Regulation by transcriptional and posttranscriptional mechanisms
19. Alteration and abnormal expression of the c-myc oncogene in human multiple myeloma
20. Application of interphase fluorescene in situ hybridization for the detection of the Burkitt translocation t(8;14)(q24;q32) in B-cell lymphomas
21. Cytogenetic study in multiple myeloma at diagnosis: Comparison of two techniques
22. Aggressive plasma cell myeloma - A terminal phase
23. Interphase and metaphase detection of the breakpoint of 14q32 translocations in B-cell malignancies by double-color fluorescence in situ hybridization
24. Detection of myc translocation in lymphoma cells by fluorescence in situ hybridization with yeast artificial chromosomes